Fluvoxamine and the Early Treatment of COVID: What does the data say?

Dr. Christy discusses the latest research on Fluvoxamine for the treatment of COVID-19:

To enlist in a trial go to:
stopcovidtrial.wustl.edu

REFERENCES:
France Observational Study with SSRI/SNRI
https://www.medrxiv.org/content/10.1101/2020.07.09.20143339v2.full.pdf

Sigma 1 Receptor Agonist activity of SSRIs
https://www.researchgate.net/publication/40728854_Sigma-1_Receptors_and_Selective_Serotonin_Reuptake_Inhibitors_Clinical_Implications_of_their_Relationship

CETF summary on Fluvoxamine:
https://www.treatearly.org/promising-drugs

Washington Post Op-Ed about Fluvoxamine:
https://www.washingtonpost.com/outlook/2021/01/27/covid-19-experimental-treatments/

Видео Fluvoxamine and the Early Treatment of COVID: What does the data say? канала Christy Risinger, MD